Product Information

SUMATRIPTAN SUCC 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2509 per EA under NDC 64980066091. Its NADAC has been published 48 times since Sep 24, 2025.

FDA first approved this application on Dec 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the sumatriptan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for SUMATRIPTAN SUCC 25 MG TABLET has been published 48 times since Sep 24, 2025, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.